Summary
Large-scale longitudinal data are often heterogeneous, spanning latent subgroups such as disease subtypes. In this paper, we present an approach called longitudinal joint cluster regression (LJCR) for penalized mixed modelling in the latent group setting. LJCR captures latent group structure via a mixture model that includes both the multivariate distribution of the covariates and a regression model for the response. The longitudinal dynamics of each individual are modeled using a random effect intercept and slope model. Inference is done via a profile likelihood approach that can handle high-dimensional covariates via ridge penalization. LJCR is motivated by questions in neurodegenerative disease research, where latent subgroups may reflect heterogeneity with respect to disease presentation, progression and diverse subject-specific factors. We study the performance of LJCR in the context of two longitudinal datasets: a simulation study and a study of amyotrophic lateral sclerosis (ALS). LJCR allows prediction of progression as well as identification of subgroups and subgroup-specific model parameters.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT01141023, PMC4239834
Funding Statement
This work has been supported by the Academy of Medical Sciences.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All the modeling part and results have been scrutinized by experts in the field of Biostatistics
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The ALS PRO-ACT data is publicly available. Parkinson's disease data (PPMI) can be found at the following link
https://nctu.partners.org/ProACT/
http://www.ppmi-info.org/access-data-specimens/download-data/